Evidence map›Paper›PMID 35228728›Full record

ArticleNature methods2022

Uncovering an overlooked consequence of phosphorylation: change in cysteine reactivity.

Markus Lakemeyer, Matthew Bogyo

Abstract readComment
PubMed Publisher
In one paragraph

Article in Nature methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Markus LakemeyerDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA. mlakemeyer@stanford.edu.ORCID http://orcid.org/0000-0001-6580-3275
Matthew BogyoDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA. mbogyo@stanford.edu.ORCID http://orcid.org/0000-0003-3753-4412

Funding

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseasesR01DK130293 · NIDDK · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2021 to 2025
$2.4M
Dual orthogonal fluorescent protease sensors for image guided surgeryR01EB028628 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2019 to 2023
$1.9M
Generation of highly selective activity based probes using chemically modified phageR01EB026285 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2018 to 2021
$1.9M
Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agentsR01EB026332 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2018 to 2021
$1.4M
NIBIB NIH HHS R01 EB026285NIBIB NIH HHS R01 EB026332NIBIB NIH HHS R01 EB028628NIDDK NIH HHS R01 DK130293
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CysteinePhosphorylationCysteine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.